Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 7,538 shares at $87.07 ($656K) on 2016-05-23, disclosed to the SEC on 2016-05-25.
Seasonal sale ($656k) by EVP, Chief Financial Officer — this insider has traded BMRN in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.07 | 3,769 | $328K | 50.0% |
| 2 | $87.07 | 3,769 | $328K | 50.0% |
| Total | $87.07 avg | 7,538 | $656K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |